2026. Reactive Angioendotheliomatosis with Atypical Features Following Immune Checkpoint Inhibitor Therapy: A Diagnostic Challenge. International Journal of Medicine & Health Research (IJMHR) (ISSN 2395-3586) . 14, 2 (Oct. 2026), 1–6. DOI:https://doi.org/10.71393/w7hjee54.